View the content of this email online

Oral session with LentiFlash® @ ASGCT21

ASGCT banner 2021
Don't miss the oral abstract session about LentiFlash®, our innovative RNA delivery technology, associated with CRISPR/Cas9 technology used on iPS cells
Separator

Pr. John De Vos, from University Hospital of Montpellier (France) will present his latest research using LentiFlash®.

 

Pr De Vos is in charge of the cell and tissue engineering department of the University Hospital of Montpellier. He is VP of the French Society for Stem Cell Research.

This oral presentation illustrates the result of 2 years of an exciting collaborative work with Flash Therapeutics.

 

https://www.flashtherapeutics.com/public/img/fleche_espace.pngPoster session Date/Time: Thursday May 13, 2021 6:30 PM - 6:45 PM in Eastern Time (ET)

 

https://www.flashtherapeutics.com/public/img/fleche_espace.pngSession title : « Efficient CRISPR-Cas9-Mediated Gene Knockout and Interallelic Gene Conversion in Human Induced Pluripotent Stem Cells Using Non-Integrative Bacteriophage-Chimeric Retrovirus-Like Particles » (#184)

 

 

Come and join us

Click Here

Follow us

Twitter Flash Therapeutics LinkedIn Flash Therapeutics Youtube Flash Therapeutics Google + Flash Therapeutics
www.flashtherapeutics.com
© Flash Therapeutics 2018

Click here to unsuscribe from the mailing list